The Canadian Rheumatology Association (CRA), with input from the Canadian Arthritis Patient Alliance (CAPA) has developed a Decision Aid for the COVID-19 Vaccine in Patients with Autoimmune Rheumatic Diseases. This Decision Aid is for an adult of age >18 years living with the following autoimmune diseases, including (but is not limited to): Juvenile Idiopathic Arthritis, Ankylosing Spondylitis/spondyloarthritis, Behcet’s disease, Myositis, Polymyalgia rheumatica, Psoriatic arthritis, Reactive arthritis, Relapsing polychondritis, Rheumatoid arthritis, Scleroderma, Sjorgen’s syndrome, Still’s disease, Systemic lupus  erythemathosus and Vasculitis.

The pamphlet was designed to help you to decide with your healthcare provider which option works best for you.